IT1252599B - Composizione farmaceutica effervescente anticefalalgica - Google Patents

Composizione farmaceutica effervescente anticefalalgica

Info

Publication number
IT1252599B
IT1252599B ITRM910963A ITRM910963A IT1252599B IT 1252599 B IT1252599 B IT 1252599B IT RM910963 A ITRM910963 A IT RM910963A IT RM910963 A ITRM910963 A IT RM910963A IT 1252599 B IT1252599 B IT 1252599B
Authority
IT
Italy
Prior art keywords
effervescent
anticefalalgica
pharmaceutical composition
compositions
solvate
Prior art date
Application number
ITRM910963A
Other languages
English (en)
Inventor
Alain Emile Edouard Schaeffer
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of ITRM910963A0 publication Critical patent/ITRM910963A0/it
Publication of ITRM910963A1 publication Critical patent/ITRM910963A1/it
Application granted granted Critical
Publication of IT1252599B publication Critical patent/IT1252599B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invenzione si riferisce a composizioni farmaceutiche effervescenti per uso orale comprendenti. una coppia effervescente costituita essenzialmente da un componente base ed un componente acido, i quali componenti reagiscono in presenza di. acqua per generale un gas, ed un composto che agisce come agonista di recettore 5HT1- simile od un suo sale o solvato fisiologicamente accettabile come ingrediente attivo. Vengono anche descritti metodi per la produzione di queste composizioni e per il loro uso nel trattamento di dolore cefalico.
ITRM910963A 1990-12-21 1991-12-20 Composizione farmaceutica effervescente anticefalalgica IT1252599B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027827A GB9027827D0 (en) 1990-12-21 1990-12-21 Pharmaceutical compositions
SG169594A SG169594G (en) 1990-12-21 1994-12-01 Effervescent pharmaceutical compositions containing a 5HT-receptor agonist

Publications (3)

Publication Number Publication Date
ITRM910963A0 ITRM910963A0 (it) 1991-12-20
ITRM910963A1 ITRM910963A1 (it) 1993-06-20
IT1252599B true IT1252599B (it) 1995-06-19

Family

ID=26298162

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910963A IT1252599B (it) 1990-12-21 1991-12-20 Composizione farmaceutica effervescente anticefalalgica

Country Status (25)

Country Link
EP (1) EP0563094B1 (it)
JP (1) JP3425949B2 (it)
KR (1) KR100188172B1 (it)
AT (1) ATE127688T1 (it)
AU (1) AU654313B2 (it)
BE (1) BE1004182A3 (it)
CA (1) CA2099585C (it)
CH (1) CH684161A5 (it)
CZ (1) CZ281042B6 (it)
DE (1) DE69113062T2 (it)
DK (1) DK0563094T3 (it)
ES (1) ES2078727T3 (it)
FR (1) FR2670674B1 (it)
GB (2) GB9027827D0 (it)
GR (1) GR3017701T3 (it)
HK (1) HK18795A (it)
IE (1) IE914482A1 (it)
IL (1) IL100452A (it)
IT (1) IT1252599B (it)
MX (1) MX9102733A (it)
NZ (1) NZ241098A (it)
RU (1) RU2110992C1 (it)
SG (1) SG169594G (it)
WO (1) WO1992011003A1 (it)
ZA (1) ZA9110052B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
IL100452A (en) 1997-02-18
AU654313B2 (en) 1994-11-03
CZ281042B6 (cs) 1996-06-12
KR100188172B1 (ko) 1999-06-01
GR3017701T3 (en) 1996-01-31
EP0563094A1 (en) 1993-10-06
EP0563094B1 (en) 1995-09-13
CA2099585C (en) 2003-09-30
GB2250917B (en) 1994-10-26
JPH06503826A (ja) 1994-04-28
NZ241098A (en) 1993-07-27
DE69113062D1 (de) 1995-10-19
FR2670674A1 (fr) 1992-06-26
DE69113062T2 (de) 1996-02-01
IE914482A1 (en) 1992-07-01
ATE127688T1 (de) 1995-09-15
ZA9110052B (en) 1992-10-28
WO1992011003A1 (en) 1992-07-09
GB9126957D0 (en) 1992-02-19
CZ122593A3 (en) 1994-02-16
BE1004182A3 (fr) 1992-10-06
GB2250917A (en) 1992-06-24
IL100452A0 (en) 1992-09-06
GB9027827D0 (en) 1991-02-13
ITRM910963A0 (it) 1991-12-20
MX9102733A (es) 1992-09-01
ES2078727T3 (es) 1995-12-16
AU9066591A (en) 1992-07-22
CH684161A5 (fr) 1994-07-29
SG169594G (en) 1995-04-28
CA2099585A1 (en) 1992-06-22
DK0563094T3 (da) 1995-12-04
JP3425949B2 (ja) 2003-07-14
FR2670674B1 (fr) 1994-05-13
HK18795A (en) 1995-02-17
RU2110992C1 (ru) 1998-05-20
ITRM910963A1 (it) 1993-06-20

Similar Documents

Publication Publication Date Title
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
IT8848441A0 (it) Derivato di 4h-benzopiran-4-one o suo sale, procedimento per produrlo e composizione farmaceutica che lo contiene come ingrediente attivo
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
IT1254915B (it) Derivati di adenosina ad attivita' a2 agonista
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
BRPI0113042B8 (pt) composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
EE200200565A (et) Vaskulaarse kahjustava toimega kombinatsioonravi
HUP0001922A2 (hu) Pirazolo[4,3-c]-piridin származékok, ezeket tartalmazó inzulinrezisztencia elleni gyógyszerkészítmények, intermedierek és eljárás előállításukra
SE0102440D0 (sv) New compound
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
NO912414L (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
HK1090062A1 (en) Colchicoside analogues
IT1261471B (it) Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego.
IT1252599B (it) Composizione farmaceutica effervescente anticefalalgica
MY135460A (en) Method of stimulating hair growth using benzopyrans
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
GB9211277D0 (en) Pharmaceutical compositions
ATE402178T1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza- benzoäcüfluoren-6-carbonsäurederivate als nmda- antagonisten

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227